6-(4-BROMO-2-FLUORO-ANILINO)-7-FLUORO-N-(2-HYDROXYETHOXY)-3H-BENZIMIDAZOLE-5-CARBOXAMIDE
UNII RM3RX36H4Y
Substance Identification & Data
This profile provides standardized clinical and technical data for 6-(4-bromo-2-fluoro-anilino)-7-fluoro-n-(2-hydroxyethoxy)-3h-benzimidazole-5-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RM3RX36H4Y.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C16H13BrF2N4O3 QTZWAOWRAYNIGD-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6-(4-bromo-2-fluoro-anilino)-7-fluoro-n-(2-hydroxyethoxy)-3h-benzimidazole-5-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.